BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8709201)

  • 1. Trypsin activation pathway of rotavirus infectivity.
    Arias CF; Romero P; Alvarez V; López S
    J Virol; 1996 Sep; 70(9):5832-9. PubMed ID: 8709201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Location of intrachain disulfide bonds in the VP5* and VP8* trypsin cleavage fragments of the rhesus rotavirus spike protein VP4.
    Patton JT; Hua J; Mansell EA
    J Virol; 1993 Aug; 67(8):4848-55. PubMed ID: 8392619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core.
    Dormitzer PR; Greenberg HB; Harrison SC
    J Virol; 2001 Aug; 75(16):7339-50. PubMed ID: 11462006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypsin cleavage stabilizes the rotavirus VP4 spike.
    Crawford SE; Mukherjee SK; Estes MK; Lawton JA; Shaw AL; Ramig RF; Prasad BV
    J Virol; 2001 Jul; 75(13):6052-61. PubMed ID: 11390607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic enhancement of rotavirus infectivity: molecular mechanisms.
    Estes MK; Graham DY; Mason BB
    J Virol; 1981 Sep; 39(3):879-88. PubMed ID: 6270356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus.
    Dunn SJ; Fiore L; Werner RL; Cross TL; Broome RL; Ruggeri FM; Greenberg HB
    Arch Virol; 1995; 140(11):1969-78. PubMed ID: 7503695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic enhancement of human rotavirus infectivity.
    Konno T; Suzuki H; Kitaoka S; Sato T; Fukuhara N; Yoshie O; Fukudome K; Numazaki Y
    Clin Infect Dis; 1993 Mar; 16 Suppl 2():S92-7. PubMed ID: 8384014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of age-dependent gastric inactivation of rhesus rotavirus in the mouse.
    Bass DM; Baylor M; Broome R; Greenberg HB
    J Clin Invest; 1992 Jun; 89(6):1741-5. PubMed ID: 1318323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The VP5 domain of VP4 can mediate attachment of rotaviruses to cells.
    Zárate S; Espinosa R; Romero P; Méndez E; Arias CF; López S
    J Virol; 2000 Jan; 74(2):593-9. PubMed ID: 10623720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of rotavirus VP4 in vivo.
    Ludert JE; Krishnaney AA; Burns JW; Vo PT; Greenberg HB
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():391-5. PubMed ID: 8601772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3.
    Padilla-Noriega L; Dunn SJ; López S; Greenberg HB; Arias CF
    Virology; 1995 Jan; 206(1):148-54. PubMed ID: 7530390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.
    Ruggeri FM; Greenberg HB
    J Virol; 1991 May; 65(5):2211-9. PubMed ID: 1850007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.
    Ludert JE; Ruiz MC; Hidalgo C; Liprandi F
    J Virol; 2002 Jul; 76(13):6643-51. PubMed ID: 12050377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of trypsin and chymotrypsin on polypeptides of human rotavirus KUN strain.
    Sato T; Kitaoka S; Suzuki H; Konno T; Ishida N
    Med Microbiol Immunol; 1987; 176(2):65-73. PubMed ID: 3033457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of rotaviruses with Hsc70 during cell entry is mediated by VP5.
    Zárate S; Cuadras MA; Espinosa R; Romero P; Juárez KO; Camacho-Nuez M; Arias CF; López S
    J Virol; 2003 Jul; 77(13):7254-60. PubMed ID: 12805424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of conserved and specific epitopes on the VP8 subunit of rotavirus VP4.
    Larralde G; Gorziglia M
    J Virol; 1992 Dec; 66(12):7438-43. PubMed ID: 1279204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus spike structure and polypeptide composition.
    Anthony ID; Bullivant S; Dayal S; Bellamy AR; Berriman JA
    J Virol; 1991 Aug; 65(8):4334-40. PubMed ID: 1649333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the trypsin cleavage site of rotavirus VP4 to a furin-sensitive form does not enhance replication efficiency.
    Komoto S; Wakuda M; Ide T; Niimi G; Maeno Y; Higo-Moriguchi K; Taniguchi K
    J Gen Virol; 2011 Dec; 92(Pt 12):2914-2921. PubMed ID: 21813706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rotavirus spike protein conformational intermediate binds lipid bilayers.
    Trask SD; Kim IS; Harrison SC; Dormitzer PR
    J Virol; 2010 Feb; 84(4):1764-70. PubMed ID: 20007281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection.
    Fleming FE; Böhm R; Dang VT; Holloway G; Haselhorst T; Madge PD; Deveryshetty J; Yu X; Blanchard H; von Itzstein M; Coulson BS
    J Virol; 2014 Apr; 88(8):4558-71. PubMed ID: 24501414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.